President Donald Trump has taken a bold step in addressing the rising cost of prescription drugs by sending letters to 17 pharmaceutical companies. He...
Jared Holz, an analyst at Mizuho Securities, provided insights on the competitive landscape of the GLP-1 medication market during a recent appearance on the...
In New York, major developments in the pharmaceutical industry are making headlines. Novo Nordisk is grappling with ongoing challenges that have raised concerns about...
URGENT UPDATE: Novo Nordisk has just announced a significant restructuring plan that will unfold during the third quarter of 2023. This decision comes as...
Eli Lilly has entered into a significant collaboration with Superluminal, a machine learning-driven startup, aiming to advance research and development in obesity treatments. This...
URGENT UPDATE: UBS has officially downgraded its rating for Novo Nordisk, the renowned Danish pharmaceutical company behind the blockbuster weight-loss drugs Ozempic and Wegovy....
A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients...